Variability between iPSCs |
Genetic background |
Increase sample size; use genome editing or RNAi on isogenic cells |
Gender/age differences |
Include gender/aged matched controls |
Clone-to-clone variability |
Study 2 or more clones per patient |
Lentiviral integration |
Use non-integrating episomal vectors or Sendai virus to reprogram |
Experimental conditions |
Plate and assay lines side-by-side with controls |
Inconsistent differentiation |
iPSC culture conditions |
Equilibrate all lines to one growth condition for all lines prior to starting the experiment |
Partially reprogrammed lines |
Validate morphology, markers, self-renewal, and teratoma formation for each line |
Protocol insufficiently robust |
Optimize differentiation protocol |
Disease gene affects differentiation |
Increase sample size and perform rescue experiments |
Memory of somatic cell lineage |
Establish controls from same somatic cell type |
Inconsistent mutant phenotype |
Outlier iPSC lines |
Present individual patient data alongside pooled data |
Allelic differences |
Sequence genes and assess genotype-phenotype relationship |
Secondary defects in source tissue |
Reprogram a cell type unaffected by the disease |